Compare MHD & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MHD | CLPT |
|---|---|---|
| Founded | N/A | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 617.9M | 494.6M |
| IPO Year | N/A | 2009 |
| Metric | MHD | CLPT |
|---|---|---|
| Price | $11.28 | $8.84 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $22.50 |
| AVG Volume (30 Days) | 360.5K | ★ 974.3K |
| Earning Date | 01-01-0001 | 03-17-2026 |
| Dividend Yield | ★ 4.16% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $36,971,000.00 |
| Revenue This Year | N/A | $48.43 |
| Revenue Next Year | N/A | $23.05 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 17.78 |
| 52 Week Low | $10.79 | $8.60 |
| 52 Week High | $12.05 | $30.10 |
| Indicator | MHD | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 29.16 | 35.73 |
| Support Level | $11.08 | $8.78 |
| Resistance Level | $11.30 | $11.74 |
| Average True Range (ATR) | 0.11 | 0.61 |
| MACD | -0.04 | -0.03 |
| Stochastic Oscillator | 15.87 | 7.11 |
Blackrock Muniholdings Fund Inc is a diversified, closed-end management investment company. Its investment objective is to provide shareholders with current income exempt from U.S. federal income taxes. The fund mainly invests its managed assets in municipal bonds rated investment grade or, if unrated, are deemed to be of comparable quality by the investment adviser at the time of investment. Its investment portfolio is mainly comprised of long-term municipal bonds with a maturity of more than ten years at the time of investment. The fund can also invest directly in such securities or synthetically through the use of derivatives.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.